UPC Dividend: Universe Pharmaceuticals Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

UPC Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	09/30/2024	09/30/2023	09/30/2022	09/30/2021	09/30/2020
Revenue	19	23	32	40	47	30
Revenue Growth (YoY)	-27%	-28%	-20%	-15%	56.99%	-9%
Cost of Revenue	13	16	21	18	22	16
Gross Profit	5	6	10	21	25	14
Selling, General & Admin	11	10	9	21	6	3
Research & Development	3	2	4	7	5	0
Operating Expenses	14	14	14	29	11	3
Other Non Operating Income (Expenses)	2	0	0	0	0	0
Pretax Income	1	-8	-4	-7	13	10
Income Tax Expense	0	0	2	0	2	2
Net Income	1	-8	-6	-8	11	7
Net Income Growth	-106%	33%	-25%	-173%	56.99%	0%
Shares Outstanding (Diluted)	0.34	0.01	0	0	0.21	0.23
Shares Change (YoY)	5,602%	132%	0%	-97%	-10%	0%
EPS (Diluted)	3.13	-626.96	-1,089.57	-1,447.01	53.67	32.39
EPS Growth	-100%	-42%	-25%	-2,796%	66%	0%
Free Cash Flow	-12	-9	1	-1	-2	6
Free Cash Flow Per Share	-34.5	-647.48	166.66	-166.66	-9.48	25.7
Gross Margin	26.31%	26.08%	31.25%	52.5%	53.19%	46.66%
Operating Margin	-42.1%	-34.78%	-9.37%	-17.5%	27.65%	33.33%
Profit Margin	5.26%	-34.78%	-18.75%	-20%	23.4%	23.33%
Free Cash Flow Margin	-63.15%	-39.13%	3.12%	-2.5%	-4.25%	20%
EBITDA	-8	-8	-3	-7	13	10
EBITDA Margin	-42.1%	-34.78%	-9.37%	-17.5%	27.65%	33.33%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-8	-8	-3	-7	13	10
EBIT Margin	-42.1%	-34.78%	-9.37%	-17.5%	27.65%	33.33%
Effective Tax Rate	0%	0%	-50%	0%	15.38%	20%